Introduction
Maternal obesity is associated with congenital birth defects, including an increased risk for neural tube defects, congenital heart defects and orofacial clefts in the offspring [1] [2] [3] . No association has been described, however, between maternal pre-pregnancy obesity and the prevalence of Down syndrome in offspring. Miscarriage may occur more often among obese women 4 . Analysis of karyotype in first trimester miscarriages showed that obese women were less likely to have aneuploidy miscarriages than normal weight women 5, 6 .
The screening procedures for detecting Down syndrome offered to pregnant women have changed over the last decades. In the past, and probably still in many countries, amniocentesis has been the sole method used, mainly offered to women above 35 years of age. At present in many countries women in early pregnancy are instead offered combined screening with ultrasound and biochemistry, with measurement of fetal nuchal translucency (NT), maternal serum free β-human chorionic gonadotropin (β-hCG) and pregnancy-associated plasma protein-A (PAPP-A), to receive their individual risk estimate for trisomy 21 7 . In the algorithm described by the Fetal Medicine Foundation (FMF) in London adjustments in the measured maternal β-hCG and PAPP-A are made for maternal weight 8, 9 .
High maternal body mass index (BMI) adversely affects the ability to visualize fetal structures by ultrasound in the second trimester 10, 11 and it appears that maternal obesity also has implications in early pregnancy for the ultrasound measurements 12 . NT was found to be thicker in the fetuses of obese women (BMI≥ 30) than in the fetuses carried by normal weight women 13 ; However this was seen as having little or no clinical relevance [14] [15] [16] In addition it has been found that as maternal BMI increases, the time required to obtain NT measurements and the failure rate increase 17 . .
The objective of this study was to determine if maternal obesity is associated with an increased risk of Down syndrome in the offspring and whether the risk estimates for trisomy
Methods
For the purpose of this study two study populations were used, referred to as study group I and II.
Study group I -population-based study of risk of Down syndrome births
This study population consisted of 1,568,604 women who had given birth in Sweden from The register is based on copies of the standardized medical record forms completed at the antenatal health care centers at the start of prenatal care, usually in gestational week 10-12, records from the delivery units, and records from the pediatric examination of the newborn.
Ninety per cent of women present themselves to the antenatal health care center during the first trimester of their pregnancy. The system is identical throughout Sweden. A detailed description and validation of the register content is available 18 . There is no nation-wide register on terminated pregnancies in Sweden with data on Social Security Number available, which make individual identification impossible. Maternal age (1-year classes) is an important confounding factor and was included in the adjusted analyses. Adjusted odds ratios (OR) were determined using the Mantel-Haenszel technique 22 . Estimates of 95% confidence intervals (95%CI) were made with a test-based method, based on the Mantel-Haenszel chi-square 22 Study group II -effect of BMI on risk estimates during pregnancy. Data were retrieved from a local clinical database (Astraia, Germany) at Linkoping University hospital, a tertiary referral center for fetal medicine. The following variables were exported from the Astraia database: maternal weight, calculated risk for trisomy 21, gestational day when the ultrasound examination was performed, NT thickness, maternal age at the ultrasound examination, PAPP-A multiples of the median (MoM), and free β-hCG
MoM. During the study period women with a risk for trisomy 21 greater than 1/300 were offered amniocentesis.
Data on maternal height were not available in the Astraia database and were therefore retrieved from the antenatal care center medical records and linked to the Astraia data set using the personal identification number held by everyone living in Sweden. The women were classified in six BMI classes as described above concerning the first study population.
Outcomes estimated over the maternal BMI strata were risk assessments for Down syndrome, NT thickness, PAPP-A MoM and free β-hCG MoM. The analyses of the variables intend to study a normal population therefore cases with a risk estimate >1/300 (where most of the cases of Down syndrome could be expected) were excluded to avoid bias of a potential association between maternal BMI and Down syndrome.
Medians with 95% CI were estimated using Analyze-it software (Analyze-it Software, Ltd, Leads, UK). In order to compare risk estimates in different BMI classes, the Wilcoxon nonparametric method was used because of the extreme skewness of data. For each maternal age class (one year) the rank sums of cases in a specific BMI class were compared with the rank sum of the reference BMI class (BMI 18.5-24.9) and the rank sum T of the former was determined with its error. The mean for these T values with its error was compared with zero.
Zero would indicate no difference.
Ethics: The Regional Ethical Review Board in Linköping has approved the study (2013/4-31).
Results

Study group I
The overall crude risk of having an infant with Down syndrome during the study period was The prevalence of obesity (BMI ≥ 30) was 10.6% distributed in obesity class I-III as follows:
class I 7.6%, class II 2.2% and class III 0.8%. Obese women (BMI ≥30) had a greater risk for giving birth to an infant with Down syndrome than did normal-weight women, OR 1.28 (95%CI 1.12-1.48) after adjustment for maternal age (one year classes). separately (data not shown) and no major differences were found.
Study group II
The prevalence of obesity was 12.9%; the corresponding rates for obesity class I-III were; class I 9.0%, class II 3.0% and class III 1.0%. Study group II had a slightly higher prevalence of obesity than women in the nationwide study group I. The risk estimates for Down syndrome show an extremely skewed distribution. Figure 2 shows the median risk in the first trimester for each BMI class, expressed as the risk per 10,000 pregnancies with the median for the normal BMI class marked as a dotted horizontal line. Women with a calculated trisomy 21
risk of >1/300 were excluded. There is a clear trend of an increased risk with increasing BMI.
Underweight women had the lowest risk for Down syndrome and morbidly obese women the highest risk estimate.
Mean measured NT thickness increased with increasing maternal BMI ( risk of >1/300 were excluded.
Since the risk for trisomy 21 markedly increases with woman's age and the BMI distribution also varies with age, adjustment for maternal age was made. Figure 5 shows the mean risk estimate for each maternal age (1-year) for the normal BMI class (18.5-24.9) and for overweight and obesity class I and II+III. A clear-cut difference is seen for obese women and at ages greater than 35 years, with higher adjusted risk for Down syndrome in older obese compared with lighter weight women.
In order to see if these effects were statistically significant, we used the Wilcoxon nonparametric test and compared the risk for obese women and normal-BMI women with a T-test (rank order test) within each maternal age. We calculated the mean T value for all ages and compared with 0 which was the expected value if no difference existed. For both BMI group 30-34.9 ( mean T = 0.81 ± 0.28, z=2.89, P=0.006) and BMI group ≥35 (mean T = 0.40 ± 0.27, z = 1.50, p=0.13) there was a higher risk for obese women than for those with normal BMI., but the difference was not statistically significant
The risk limit above which amniocentesis was offered during the study period was a risk for trisomy 21 higher than 1/300. Table 1 show that the percentages of women in each BMI class with a risk estimate >1/300 differed according to BMI class. Since the age distribution differed between the BMI classes, we calculated the expected number of such cases in each BMI class, adjusting for maternal age (one year class). The expected number of cases with a >1/300 risk within each BMI class was thus estimated from the age-specific risk for Down syndrome multiplied with the number of individuals in that BMI and age class. As is seen in Table 1 , the observed and expected numbers were very close, suggesting that after controlling for maternal age, the rate of Down syndrome risk >1/300 was not affected by maternal BMI.
Discussion
This large population-based cohort study based on Swedish Medical Birth Register data showed that the risk of giving birth to an infant with Down syndrome was 28% higher among obese women compared to normal weight women after adjustment for one-year maternal age.
This could be due to an increased risk of having a trisomy 21 conception related to obesity or could be because obesity makes prenatal detection of trisomy 21 more difficult. When evaluating study group II a moderate effect of maternal obesity on the NT thickness measurement was found: the NT thickness increased with increasing BMI, which increases the risk estimate for Down syndrome. Both β -hCG and PAPP-A are adjusted for maternal weight in the algorithm. However, the proportion of women who had a risk estimate >1/300
(which was the value that had to be exceeded for amniocentesis to be offered) increased with BMI but was completely explained by the distribution of maternal age within each BMI class.
Thus there is no evidence that any effects of BMI on the components of first trimester combined screen affects the risk estimate past the critical level. These findings are in accordance with earlier studies 7, [13] [14] [15] [16] .
It should be emphasized that the risk estimates from the combined screening studies (Study group II) have a minor effect on the results from Study group I as such screening was only seldom performed in the whole country during the study period. If a high BMI is associated with an inadequate prenatal identification of trisomy 21, the explanation must be sought in other factors. One possibility is that obesity may affect prenatal detection of structural fetal defects or findings of soft markers associated with Down syndrome in the second trimester of pregnancy, leading to lower rates of amniocentesis and trisomy 21 diagnosis in the midtrimester 11 . It appears that it is more difficult to detect structural fetal defects in obese women at the second trimester screening than in women of normal weight 12, 23, 10 . A higher detection rate of anomalies among lean and normal-weight women could provide the reason for amniocentesis and abnormal results at amniocentesis could lead to higher rates of termination of pregnancy than among obese women. A systematic search of US Englishlanguage articles (1995-2011) by Natoli reporting data for pregnancies with definitive prenatal diagnosis of Down syndrome, showed that termination rates varied with maternal age, gestational age, and maternal ethnicity 24 . However maternal BMI in relation to termination of Down syndrome pregnancies was not evaluated in the Natoli study.
Obesity is linked to low socioeconomic status and a second possibility is that obese women may attend antenatal care to a lesser extent than normal weight women 25, 26 . The socioeconomic status of the women may also affect either the woman's acceptance of an offer of prenatal diagnosis or the woman's acceptance of amniocentesis if the risk of Down syndrome is increased. The proportion of women who were offered but declined prenatal screening with combined ultrasound and biochemistry during the study period was 18%.
Unfortunately the BMIs of these women was not recorded. In our cohort of screened women with a risk for Down syndrome >1/300 there were no differences in mean weight between women accepting and declining amniocentesis.
If the above factors do not explain the association between high maternal BMI and increased risk for Down syndrome infants, we should consider an effect of obesity on the risk for the non-disjunction process underlying Trisomy 21. Some studies have suggested that nutritional factors with insufficient folic acid supplementation could affect the Down risk but a recent large study found little evidence for this -only at a maternal age ≥35 and a meiosis II error was an association seen, but this could be the result of multiple testing 27 .
The advantage of population-based register studies is the large number of individuals available for evaluation, which gives high statistical power. The availability of a sufficient number of study subjects made it possible to evaluate the three subgroups of obesity suggested by WHO, obesity class I-III. The drawback could be the large number of health 14 care units involved, which could result in a difference in the assessment of risk of Down syndrome infants, but it seems unlikely that such variability is related to maternal BMI.
Finally the possibility exists that there is a real direct effect of obesity or conditions associated with obesity and the origin of chromosomal non-disjunction but the possible mechanisms behind such an effect are not yet known.
Conclusion
Prenatal screening for Down syndrome with combined ultrasound and biochemistry offered to women in the first trimester seems equally effective irrespective of maternal BMI.
Maternal obesity increases the risk for Down syndrome in the offspring, and the effect is most prominent at older maternal ages. 
